<bill session="119" type="h" number="1051" updated="2025-03-11T14:13:22Z">
  <state datetime="2025-02-06">REFERRED</state>
  <status>
    <introduced datetime="2025-02-06"/>
  </status>
  <introduced datetime="2025-02-06"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.</title>
    <title type="display">To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001315"/>
  <cosponsors/>
  <actions>
    <action datetime="2025-02-06">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-02-06" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
</bill>
